Thromboprophylaxis in Orthopedic Practice

Evidence-Based Orthopedics

Volumn , Issue , 2011, Pages 56-71

  Kwek, Ernest ^a   Buckley, Richard E ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Anticoagulation; Deep vein thrombosis; Extended duration prophylaxis; Inferior vena caval filter; Mechanical thromboprophylaxis; Pulmonary embolism; Thromboprophylaxis; Venous thromboembolism

Indexed keywords

EID: 84885831508     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444345100.ch8     Document Type: Chapter

References (137)

1. Anderson FA Jr., Wheeler HB, Goldberg RJ, et al. A populationbased perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991;151:933-8.
2. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998;158:585-93.
3. White RH. The epidemiology of venous thromboembolism. Circulation 2003;107, I4-8.
4. Coon WW. Epidemiology of venous thromboembolism. Ann Surg 1977;186:149-4.
5. Gillum RF. Pulmonary embolism and thrombophlebitis in the United States, 1970-1985. Am Heart J 1987;114:1262-4.
6. White RH, Zhou H, Romano PS. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 1998;128:737-40.
7. Hirst AE, Gore I, Tanaka K, et al. Myocardial infarction and pulmonary embolism. Arch Pathol 1965;80:365-70.
8. Klatsky AL, Armstrong MA, Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol 2000;85:1334-7.
9. Murin S, Romano PS, White RH. Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism. Thromb Haemost 2002;88:407-14.
10. Hansson PO, Welin L, Tibblin G, et al. Deep vein thrombosis and pulmonary embolism in the general population. "The Study of Men Born in 1913." Arch Intern Med 1997;157: 1665-70.
11. Kakkar VV, Howe CT, Flanc C, Clarke MB. Natural history of postoperative deep-vein thrombosis. Lancet 1969;ii, 230-2.
12. Heit JA, Cohen AT, Anderson FA, VTE Impact Assessment Group. Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the U.S. Blood 2005;106:267a.
13. Rosendaal FR. Risk factors for venous thrombotic disease. Thromb Haemost 1999;82:610-19.
14. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999;353:1167-73.
15. Anderson FA, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003;107:I9-16.
16. Edmonds MJ, Crichton TJ, Runciman WB. Evidence-based risk factors for postoperative deep vein thrombosis. ANZ J Surg 2004;74:1082-97.
17. Geerts WH, Bergqvist D, Graham F, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008;133:318-453S.
18. Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA 2003;290:1868-74.
19. Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008;371:387-94.
20. Spyropoulos AC, Hurley JS, Ciesla GN, de Lissovoy G. Management of acute proximal deep vein thrombosis: pharmacoeconomic evaluation of outpatient treatment with enoxaparin vs inpatient treatment with unfractionated heparin. Chest 2002;122:108-14.
21. Fancher TL, White RH, Kravitz RL. Combined use of rapid D-dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis: systematic review. BMJ 2004;329:821-8.
22. Anderson DR, Wells PS, Stiell I, MacLeod B, Simms M, Gray L, et al. Management of patients with suspected deep vein thrombosis in the emergency department: combining use of a clinical diagnosis model with d-dimer testing. J Emerg Med 2000;19: 225-30.
23. Perrier A, Desmarais S, Miron MJ, de Moerloose P, Lepage R, Slosman D, et al. Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet 1999;353:190-5.
24. Bucek RA, Koca N, Reiter M, Haumer M, Zontsich T, Minar E. Algorithms for the diagnosis of deep-vein thrombosis in patients with low clinical pretest probability. Thromb Res 2002;105:43-7.
25. Kraaijenhagen RA, Piovella F, Bernardi E, Verlato F, Beckers EA, Koopman MM, et al. Simplification of the diagnostic management of suspected deep vein thrombosis. Arch Intern Med 2002;162:907-11.
26. Shields GP, Turnipseed S, Panacek EA, Melnikoff N, Gosselin R, White RH. Validation of the Canadian clinical probability model for acute venous thrombosis. Acad Emerg Med 2002;9: 561-6.
27. Wells PS, Anderson DR, Bormanis J, Guy F, Mitchell M, Lewandowski B. SimpliRED d-dimer can reduce the diagnostic tests in suspected deep vein thrombosis. Lancet 1998;351:1405-6.
28. Ginsberg JS, Kearon C, Douketis J, Turpie AG, Brill-Edwards P, Stevens P, et al. The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosis. Arch Intern Med 1997;157: 1077-81.
29. Bates SM, Kearon C, Crowther M, Linkins L, O'Donnell M, Douketis J, et al. A diagnostic strategy involving a quantitative latex d-dimer assay reliably excludes deep venous thrombosis. Ann Intern Med 2003;138:787-94.
30. Kearon C, Ginsberg JS, Douketis J, Crowther M, Brill-Edwards P, Weitz JI, et al. Management of suspected deep venous thrombosis in outpatients by using clinical assessment and D-dimer testing. Ann Intern Med 2001;135:108-11.
31. Schutgens RE, Ackermark P, Haas FJ, Nieuwenhuis HK, Peltenburg HG, Pijlman AH, et al. Combination of a normal D-dimer concentration and a non-high pretest clinical probability score is a safe strategy to exclude deep venous thrombosis. Circulation 2003;107:593-7.
32. Tick LW, Ton E, van Voorthuizen T, Hovens MM, Leeuwenburgh I, Lobatto S, et al. Practical diagnostic management of patients with clinically suspected deep vein thrombosis by clinical probability test, compression ultrasonography, and d-dimer test. Am J Med 2002;113:630-5.
33. Aguilar C, Martinez A, Del Rio C, Vazquez M, Rodriguez FJ. Diagnostic value of D-dimer in patients with a moderate pretest probability of deep venous thrombosis. Br J Haematol 2002;118:275-7.
34. Wells PS, Owen C, Doucette S, et al. Does this patient have deep vein thrombosis? JAMA 2006; 295:199-207.
35. Goodacre S, Sampson F, Thomas S, et al. Systematic review and meta-analysis of the diagnostic accuracy of ultrasonography for deep vein thrombosis. BMC Med Imaging 2005;5:6.
36. Segal JB, Eng J, Tamariz LJ, Bass EB. Review of the evidence on diagnosis of deep venous thrombosis and pulmonary embolism. Ann Fam Med 2007;5:63-73.
37. Winer-Muram HT, Rydberg J, Johnson MS, et al. Suspected acute pulmonary embolism: evaluation with multi-detector row CT versus digital subtraction pulmonary arteriography. Radiology 2004;233:806-15.
38. Remy-Jardin M, Remy J, Wattinne L, Giraud F. Central pulmonary thromboembolism: diagnosis with spiral volumetric CT with the single-breath-hold technique-comparison with pulmonary angiography. Radiology 1992;185:381-7.
39. Blum AG, Delfau F, Grignon B, et al. Spiral-computed tomography versus pulmonary angiography in the diagnosis of acute massive pulmonary embolism. Am J Cardiol 1994;74:96-8.
40. Goodman LR, Curtin JJ, Mewissen MW, et al. Detection of pulmonary embolism in patients with unresolved clinical and scintigraphic diagnosis: helical CT versus angiography. AJR Am J Roentgenol 1995;164:1369-74.
41. Remy-Jardin M, Remy J, Deschildre F, et al. Diagnosis of pulmonary embolism with spiral CT: comparison with pulmonary angiography and scintigraphy. Radiology 1996;200:699-706.
42. Christiansen F. Diagnostic imaging of acute pulmonary embolism. Acta Radiol Suppl 1997;410:1-33.
43. Drucker EA, Rivitz SM, Shepard JA, et al. Acute pulmonary embolism: assessment of helical CT for diagnosis. Radiology 1998;209:235-41.
44. Qanadli SD, Hajjam ME, Mesurolle B, et al. Pulmonary embolism detection: prospective evaluation of dual-section helical CT versus selective pulmonary arteriography in 157 patients. Radiology 2000;217:447-55.
45. Velmahos GC, Vassiliu P, Wilcox A, et al. Spiral computed tomography for the diagnosis of pulmonary embolism in critically ill surgical patients: a comparison with pulmonary angiography. Arch Surg 2001;136:505-11.
46. Arcelus JI, Caprini JA, Reyna JJ. Finding the right fit: effective thrombosis risk stratification in orthopedic patients. Orthopedics 2000;23:633S-8S.
47. Clagett GP, Anderson FA Jr, Geerts W, et al. Prevention of venous thromboembolism. Fifth ACCP Consensus Conference on Antithrombotic Therapy. Chest 1998;114:531-60S.
48. Edmonds MJR, Crichton TJH, Runciman WB, Pradhan M. Evidence-based risk factors for postoperative deep vein thrombosis. ANZ J Surg 2004;74:1082-97.
49. Glotzbecker MP, Bono CM, Wood KB, Harris MB. Thromboembolic disease in spinal surgery. Spine 2009;34: 291-303.
50. Teasell RW, Hsieh JT, Aubut JA, Eng JJ, Krassioukov A, Tu L; Spinal Cord Injury Rehabilitation Evidence Review Research Team. Venous thromboembolism after spinal cord injury. Arch Phys Med Rehabil 2009;90:232-45.
51. Spinal Cord Injury Thromboprophylaxis Investigators. Prevention of venous thromboembolism in the rehabilitation phase after spinal cord injury: prophylaxis with low-dose heparin or enoxaparin. J Trauma 2003;54:1111-15.
52. Green D, Lee MY, Lim AC, et al. Prevention of thromboembolism after spinal cord injury using low-molecular-weight heparin. Ann Intern Med 1990;113:571-4.
53. Ramos J, Perrotta C, Badariotti G, Berenstein G. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy. Cochrane Database Syst Rev 2008;4:CD005259.
54. Canata GL, Chiey A. Prevention of venous thromboembolism after ACL reconstruction: a prospective, randomized study. ISAKOS (International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine) 2003, Poster 71-2003.
55. Michot M, Conen D, Holtz D, Erni D, Zumstein MD, Ruflin GB, et al. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: A randomized trial of prophylaxis with low-molecular weight heparin. Arthroscopy 2002;18:257-63.
56. Roth P. Prophylaxis of deepvein thrombosis in outpatients undergoing arthroscopic meniscus operation [Thromboembolieprophylaxe bei ambulant durchgefürten arthroskopischen Meniskusoperationen]. Orthop Praxis 1995;5:345-8.
57. Wirth T, Schneider B, Misselwitz F, Lomb M, Tüylü H, Egbring R, et al. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (Reviparin): Results of a randomized controlled trial. Arthroscopy 2001;17: 393-9.
58. Slobogean GP, Lefaivre KA, Nicolaou S, O'Brien PJ. A systematic review of thromboprophylaxis for pelvic and acetabular fractures. J Orthop Trauma 2009;23:379-384.
59. Steele N, Dodenhoff RM, Ward AJ, et al. Thromboprophylaxis in pelvic and acetabular trauma surgery. The role of early treatment with low molecular-weight heparin. J Bone Joint Surg Br 2005;87:209-212.
60. Abelseth G, Buckley RE, Pineo GR, Hull R, Rose MS. Incidence of deep-vein thrombosis in patients with fractures of the lower extremity distal to the hip. J Orthop Trauma 1996;10:230-5.
61. Goel DP, Buckley RE, deVries G, Abelseth G, et al. Prophylaxis of deep-vein thrombosis in fractures below the knee: a prospective randomized controlled trial. J Bone Joint Surg Br 2009;91: 388-94.
62. Amaragiri SV, Lees T. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev 2000;1:CD001484.
63. Allan A,Williams JT, Bolton JP, LeQuesne LP. The use of graduated compression stockings in the prevention of postoperative deep vein thrombosis. Br J Surg 1983;70:172-4.
64. Holford CP. Graded compression stockings for preventing deep vein thrombosis. Br Med J 1976;ii:969-70.
65. Hui AC, Heras-Palou C, Dunn I, Triffitt PD, Crozier A, Imeson J, et al. Graded compression stockings for prevention of deepvein thrombosis after hip and knee replacement. J Bone Joint Surg Br 1996;78:550-4.
66. Scurr JH, Ibrahim SZ, Faber RG, Le Quesne LP. The efficacy of graduated compression stockings in the prevention of deep vein thrombosis. Br J Surg 1977;64:371-3.
67. Tsapogas MJ, Goussous M, Peabody RA, Karmody AM, Eckert C. Postoperative venous thrombosis and the effectiveness of prophylactic measures. Arch Surg 1971;103:561-7.
68. Turner GM, Cole SE, Brooks JH. The efficacy of graduated compression stockings in the prevention of deep vein thrombosis after major gynaecological surgery. Br J Obstet Gynaecol 1984;91:588-91.
69. Turpie AGG, Hirsh J, Gent M, Julian D, Johnson J. Prevention of deep vein thrombosis in potential neurosurgical patients: A randomized trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression with control. Arch Intern Med 1989;149:679-81.
70. Handoll HH, Farrar MJ, McBirnie J, et al. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. Cochrane Database Syst Rev 2002;4:CD000305.
71. Araujo A, Atallah A. Individual patient data (as supplied 4 July 1998). Data tables. Atallah A., personal communication, May 26, 1998.
72. Silvestre JMS. Randomised controlled trial with low molecular weight heparin and intermittent pneumatic compression in the prevention of deep venous thrombosis in patients submitted to a surgical treatment of lower limb fractures (dissertation). Escola Paulista de Medicina, Sao Paulo (SP), 1994.
73. Fisher CG, Blachut PA, Salvian AJ, Meek RN, O'Brien PJ. Effectiveness of pneumatic leg compression devices for the prevention of thromboembolic disease in orthopaedic trauma patients: A prospective, randomized study of compression alone versus no prophylaxis. J Orthop Trauma 1995;9:1-7.
74. Hartman JT, Pugh JL, Smith RD, Robertson WW, Yost RP, Janssen HF. Cyclic sequential compression of the lower limb in prevention of deep venous thrombosis. J Bone Joint Surg Am 1982;64:1059-62.
75. Gargan MF, Lawrence J, Thomas H, Trundle H, Fairbank JTC. Thromboembolic prophylaxis following hip fracture using a foot pump (A-V impulse system). Unpublished trial (abstract).
76. Stranks GJ, MacKenzie NA, Grover ML, Fail T. The A-V impulse system reduces deep-vein thrombosis and swelling after hemiarthroplasty for hip fracture. J Bone Joint Surg Br 1992;74: 775-8.
77. Kakkos SK, Caprini JA, Geroulakos G, Nicolaides AN, Stansby GP, Reddy DJ. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolismin high-risk patients. Cochrane Database Syst Rev 2008;4:CD005258.
78. Turpie AGG, Bauer KA, Caprini JA, Comp PC, Gent M, Muntz JE, on behalf of the APOLLO Investigators. Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. J Thromb Haemost 2007;5: 1854-61.
79. Woolson ST,Watt JM. Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin. J Bone Joint Surg Am 1991;73:507-12.
80. Crowther MA. Inferior vena cava filters in the management of venous thromboembolism. Am J Med 2007;120, S13-17.
81. Weichman K, Ansell JE. Inferior vena cava filters in venous thromboembolism. Prog Cardiovasc Dis 2006;49:98-105.
82. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep venous thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 1998;338:409-415.
83. PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC randomized study. Circulation 2005;112: 416-422.
84. Young T, Tang H, Aukes J, Hughes R. Vena caval filters for the prevention of pulmonary embolism. Cochrane Database Syst Rev 2007;4:CD006212.
85. Linsenmaier U, Rieger J, Schenk F, Rock C, Mangel E, Pfeifer KJ. Indications, management, and complications of temporary inferior vena cava filters. Cardiovasc Intervent Radiol 1998;21: 464-9.
86. Shorr AF, Kwong LM, Sarnes M, et al. Venous thromboembolism after orthopedic surgery: Implications of the choice of prophylaxis. Thromb Res 2007;121:17-24.
87. Muntz J, Scott DA, Lloyd A, Egger M. Major bleeding rates after prophylaxis against venous thromboembolism: Systematic review, meta-analysis, and cost implications. Int J Technol Assess Health Care 2004;20:405-14.
88. Bauer KA, Eriksson BI, LassenMR, et al. Fondaparinux compared with enoxaparin for the prevention of venous throm boembolism after elective major knee surgery. N Engl J Med 2001;345:1305-10.
89. Colwell CW, Collis DK, Paulson R, et al. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge. J Bone Joint Surg Am 1999;81:932-40.
90. Colwell CW, Spiro TE, Trowbridge AA, et al. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group. J Bone Joint Surg Am 1994;76:3-14.
91. Colwell CW, Spiro TE, Trowbridge AA, et al. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Enoxaparin Clinical Trial Group. Clin Orthop 1995;321:19-27.
92. Eriksson BI, Bauer KA, Lassen MR, et al. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med 2001;345:1298-304.
93. Fauno P, Suomalainen O, Rehnberg V, et al. Prophylaxis for the prevention of venous thromboembolism after total knee arthroplasty. A comparison between unfractionated and low-molecularweight heparin. J Bone Joint Surg Am 1994;76:1814-18.
94. Fitzgerald RHJ, Spiro TE, Trowbridge AA, et al. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel group comparison of enoxaparin and warfarin. J Bone Joint Surg Am 2001;83:900-6.
95. Francis CW, Pellegrini VD, Totterman S, et al. Prevention of deep-vein thrombosis after total hip arthroplasty. Comparison of warfarin and dalteparin. J Bone Joint Surg Am 1997;79: 1365-72.
96. Freick H, Haas S. Prevention of deep vein thrombosis by low molecular-weight heparin and dihydroergotamine in patients undergoing total hip replacement. Thromb Res 1991;63: 133-43.
97. Haas S, Fareed J, Breyer HG, et al. Prevention of severe venous thromboembolism after hip and knee replacement surgery-A randomized comparison of low-molecular weight heparin with unfractionated heparin. Presented to ASH, December 7-11, 2001, Orlando. Abstract 2957. Blood 2001;98.
98. Hamulyak K, Lensing AW, van der Meer J, et al. Subcutaneous low-molecular weight heparin or oral anticoagulants for the prevention of deep-vein thrombosis in elective hip and knee replacement? Fraxiparine Oral Anticoagulant Study Group. Thromb Haemost 1995;74:1428-31.
99. Hull R, Raskob G, Pineo G, et al. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 1993;329:1370-6.
100. Hull RD, Pineo GF, Francis C, et al. Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: A double blind, randomized comparison. The North American Fragmin Trial Investigators. Arch Intern Med 2000;160:2199-207.
101. Hull RD, Raskob GE, Pineo GF, et al. Subcutaneous low molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective. Arch Intern Med 1997;157:298-303.
102. Kakkar VV, Howes J, Sharma V, Kadziola Z. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of postoperative venous thromboembolism. The Bemiparin Assessment group. Thromb Haemost 2000;83:523-9.
103. Lassen MR, Bauer KA, Eriksson BI, et al. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: A randomised double-blind comparison. Lancet 2002;359: 1715-20.
104. Lassen MR, Borris LC, Christiansen HM, et al. Heparin/dihydroergotamine for venous thrombosis prophylaxis: Comparison of low-dose heparin and low molecular weight heparin in hip surgery. Br J Surg 1988;75:686-9.
105. Leclerc JR, Geerts WH, Desjardins L, et al. Prevention of venous thromboembolism after knee arthroplasty. A randomized, double-blind trial comparing enoxaparin with warfarin. Ann Intern Med 1996;124:619-26.
106. Levine MN, Hirsh J, Gent M, et al. Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin. Ann Intern Med 1991;114:545-51.
107. Planes A, Vochelle N, Mazas F, et al. Prevention of postoperative venous thrombosis: A randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement. Thromb Haemost 1988;60:407-10.
108. The German Hip Arthroplasty Trial (GHAT) Group. Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement: A randomized trial. Arch Orthop Trauma Surg 1992;111:110-20.
109. Turpie AGG, Bauer KA, Eriksson BI, et al. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: A randomised double-blind trial. Lancet 2002;359: 1726.
110. Weitz JI. Unanswered questions in venous thromboembolism. Thromb Res 2009;123, S2-10.
111. Palmer A J, Koppenhagen K, Kirchhof B, Weber U, Bergemann R. Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery: a meta-analysis of randomised clinical trials. Haemostasis 1997;27:75-84.
112. Pulmonary Embolism Prevention (PEP) Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) Trial. Lancet 2000;355:1295-302.
113. Sharrock NE, Go G, Harpel PC, Ranawat CS, Sculco TP, Salvati EA. Thrombogenesis during total hip arthroplasty. Clin Orthop 1995;319:16-27.
114. Raskob GE, Hirsh J. Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery. Chest 2003;124:379-385S.
115. Hull RD, Brant RF, Pineo GF, et al. Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement. Arch Intern Med 1999;159:137-41.
116. Turpie AGG, Levine MN, Hirsh J, et al. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 1986;315:925-9.
117. Planes A, Vochelle N, Mazar F, et al. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement. Thromb Haemost 1988;60:407-10.
118. Levine MN, Hirsh J, Gent M. Prevention of deep vein thrombosis after elective hip surgery: a randomized trial comparing low molecular weight heparin with standard unfractionated heparin. Ann Intern Med 1991;114:545-51.
119. Planes A, Chastang CL, Vochelle N, et al. Comparison of antithrombotic efficacy and haemorrhagic side effects of reviparinsodium versus enoxaparin in patients undergoing total hip replacement surgery. Blood Coagul Fibrinolysis 1993;4, S33-8.
120. Spiro TE, Johnson CJ, Christie MJ, et al. Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Ann Intern Med 1994; 121:81-9.
121. Samama CM, Clergue F, Barre J, et al. Low molecular weight heparin associated with spinal anaesthesia and gradual compression stockings in total hip replacement surgery. Br J Anaesth 1997;78:660-5.
122. Hull RD, Pineo GF, Francis C, Bergqvist D, et al. Low-molecularweight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients. Arch Intern Med 2000;160:2199-207.
123. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomized trials. Lancet 2001;358:9-15.
124. Planes A, Vochelle N, Darmon JY, Fagola M, Bellaud M, Huet Y. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo. Lancet 1996;348(9022):224-8.
125. Dahl OE, Andreassen G, Aspelin T, et al. Prolonged thromboprophylaxis following total hip replacement surgery-results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin). Thromb Haemost 1997;77: 26-31.
126. Hull RD, Pineo GF, Francis C, et al. Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double blind, randomized comparison. North American Fragmin Trial Investigators. Arch Intern Med 2000;160:2208-15.
127. Heit JA, Elliott CG, Trowbridge AA, Morrey BF, Gent M, Hirsh J, for the Ardeparin Arthroplasty Study Group. Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000;132:853-61.
128. Comp PC, Spiro TE, Friedman RJ, et al. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. J Bone Joint Surg Am 2001;83:336-45.
129. Bergqvist D, Benoni G, Bjorgell O, et al. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous throm-boembolism after total hip replacement. N Engl J Med 1996;335:696-700.
130. Lassen MR, Borris LC, Anderson BS, et al. Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty-the Danish Prolonged Prophylaxis (DaPP) Study. Thromb Res 1998;89: 281-7.
131. Manganelli D, Pazzagli M, Mazzantini D, et al. Prolonged prophylaxis with unfractionated heparin is effective to reduce delayed deep vein thrombosis in total hip replacement. Respiration 1998;65:369-74.
132. Haentjens P. Venous thromboembolism after total hip arthroplasty: a review of incidence and prevention during hospitalization and after hospital discharge. Acta Orthop Belg 2000;66:1-8.
133. Skedgel C, Goeree R, Pleasance S, et al. The cost-effectiveness of extended-duration antithrombotic prophylaxis after total hip arthroplasty. J Bone Joint Surg Am 2007;89:819-28.
134. Xabregas A, Gray L, Ham JM. Heparin prophylaxis of deep vein thrombosis in patients with a fractured neck of the femur. Med J Aust 1978;1:620-2.
135. Bergqvist D, Efsing HO, Hallbook T, Hedlund T. Thromboembolism after elective and post-traumatic hip surgery-a controlled prophylactic trial with dextran 70 and low-dose heparin. Acta Chir Scand 1979;145:213-18.
136. Jorgensen PS, Knudsen JB, Broeng L, Josephsen L, Bjerregaard P, Hagen K, et al. The thromboprophylactic effect of a lowmolecular weight heparin (Fragmin) in hip fracture surgery. A placebo-controlled study. Clin Orthop Related Res 1992;278: 95-100.
137. Kiviluoto O, Julkunen H, Honkonen K. Prevention of venous thromboemboli with low doses of heparin in patients with proximal femur fractures. Zentralbl Chir 1980;105:460-4.